reviewEndocrine ReviewsSep 12, 2014BRONZE OA

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

University of Toronto · Lunenfeld-Tanenbaum Research Institute

PubMed
Indexed incrossrefpubmed

Abstract

Dipeptidyl peptidase-4 (DPP4) is a widely expressed enzyme transducing actions through an anchored transmembrane molecule and a soluble circulating protein. Both membrane-associated and soluble DPP4 exert catalytic activity, cleaving proteins containing a position 2 alanine or proline. DPP4-mediated enzymatic cleavage alternatively inactivates peptides or generates new bioactive moieties that may exert competing or novel activities. The widespread use of selective DPP4 inhibitors for the treatment of type 2 diabetes has heightened interest in the molecular mechanisms through which DPP4 inhibitors exert their pleiotropic actions. Here we review the biology of DPP4 with a focus on: 1) identification of…

Citation impact

604
total citations
FWCI
16.41
Percentile
100%
References
242
Citations per year

Authors

2

Topics & keywords

Keywords
  • Dipeptidyl peptidase-4
  • Dipeptidyl peptidase
  • Transmembrane protein
  • Enzyme
  • Chemistry
  • Small molecule
  • Biochemistry
  • Drug discovery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding